An interventional study of short foot cast and short leg cast in Acute Closed Fracture of Proximal Fifth Metatarsal (Zone II), sponsored by Jatupon Kongtharvonskul. Completed at 1 site in Thailand. Open to participants aged 15 Years and older. Per ClinicalTrials.gov, last updated 2018-09-18.
Sponsored by Jatupon Kongtharvonskul · Not applicable, Interventional, and Treatment
This study aims to compare outcomes of short leg cast and foot cast for treatment acute fifth metatarsal fracture (Zone II).
A randomized controlled trial will conducts between January 2017 and January 2019, participants with acute fifth metatarsal fracture (Zone II) will recruit for this study at the orthopedic outpatient clinic of a police general hospital, Bangkok, Thailand. A total of 100 patients will randomly allocate to receive foot cast or short leg cast. acute closed fracture of proximal fifth metatarsal (zone II) patients.
44 studies on the registry are indexed under Fractures, Closed; 4 are open to participants now.
This study's enrollment of 72 is above the median of 45 across 34 interventional studies indexed under Fractures, Closed.
Browse Fractures, Closed studies →This is the only study on the registry with Jatupon Kongtharvonskul as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Inclusion Criteria:acute closed fracture of proximal fifth metatarsal (zone II) with following criteria
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Cancer (malignancy)
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Device: short foot cast
Device: short leg cast
metatarsal foot cast
full short leg cast
VAS
visual analog score
Time frame: 8 weeks
AOFAS
foot score
Time frame: 8 weeks
union rate
radiographic union
Time frame: 8 weeks
complication
skin ulcer or compartment syndrome
Time frame: 8 weeks
rescue medication
paracetamol or NSAIDs
Time frame: 8 weeks
Plan to share: No
No publications or documents are linked to this record.
Ran from Jan 2017 to primary completion in Sep 2018, 19 months.
Of 14 interventional studies with no phase under Fractures, Closed, half reached primary completion within 36 months of starting (the median), counting those still running; a quarter within 28 and three quarters within 49. This study's 19 months is below that.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Sep 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.